转移性尿路上皮癌一线治疗方案的网状Meta分析 点击下载
论文标题: 转移性尿路上皮癌一线治疗方案的网状Meta分析
英文标题:
中文摘要: 目的 采用网状Meta分析方法系统评价不同治疗方案用于转移性尿路上皮癌一线治疗的有效性。方法计算机检索PubMed、theCochraneLibrary、Embase、万方数据、中国知网和维普网,检索用于转移性尿路上皮癌一线治疗的随机对照临床试验(RCTs),检索时限自2010年1月1日至2024年1月31日。筛选文献、提取资料后,对纳入研究进行风险偏倚评价。采用R4.3.2软件进行网状Meta分析。结果共纳入了11项RCTs,包括14种治疗措施。在客观缓解率方面,各组间差异无统计学意义,帕博利珠单抗联合吉西他滨及顺铂方案排第一的概率最大。在无进展生存期(PFS)和总生存期(OS)方面,各组间差异无统计学意义,维恩妥尤单抗联合帕博利珠单抗在延长PFS方面有优于吉西他滨联合顺铂方案的趋势[HR=0.45,95%CI(0.20,1.06),P=0.049],且其在PFS和OS中排第一的概率均最大。结论在转移性尿路上皮癌的一线治疗中,维恩妥尤单抗联合帕博利珠单抗可能在延长生存期方面更有优势。
英文摘要: OBJECTIVE To systematically evaluate the effectiveness of different treatment regimens as first-line treatment for metastatic urothelial carcinoma (UC) using a network meta-analysis (NMA) approach. METHODS Electronic databases including PubMed, the Cochrane Library, Embase, Wanfang Data, CNKI, and VIP were searched for randomized controlled clinical trials (RCTs) on first-line treatment for metastatic UC from January 1, 2010 to January 31, 2024. After literature screening and data extraction, a risk of bias assessment of included studies was conducted. R software (version 4.3.2) was used to perform the NMA. RESULTS A total of 11 RCTs involving 14 treatment interventions were included. No significant differences were noted in objective response rate among groups, with the combination of pembrolizumab, gemcitabine and cisplatin having the highest probability of ranking first. Regarding progression-free survival (PFS) and overall survival (OS), no significant differences were observed among groups, while enfortumab vedotin combined with pembrolizumab showed a trend towards better PFS extension compared to gemcitabine combined with cisplatin [HR=0.45, 95%CI(0.20,1.06), P=0.049], and it had the highest probability of ranking first in both PFS and OS. CONCLUSIONS The combination of enfortumab vedotin and pembrolizumab may have an advantage in prolonging survival in the first-line treatments for metastatic UC.
期刊: 2024年第35卷第22期
作者: 邱学佳;任炳楠;方灵芝;连玉菲;吴玉佩;董占军
英文作者: QIU Xuejia,REN Bingnan,FANG Lingzhi,LIAN Yufei,WU Yupei,DONG Zhanjun
关键字: 转移性尿路上皮癌;网状Meta分析;帕博利珠单抗;维恩妥尤单抗;吉西他滨;顺铂
KEYWORDS: metastatic urothelial carcinoma; network meta-analysis; pembrolizumab; enfortumab vedotin; gemcitabine;
总下载数: 81次
本日下载数: 2次
本月下载数: 81次
文件大小: 619.60Kb

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!